DOI: 10.1002/ccr3.73227 ISSN: 2050-0904
A Challenging Case of Advanced Cardiac Sarcoidosis Refractory to Infliximab Therapy
Manal Ibrahim, Mansimran Singh Dulay, Kshama Wechalekar, Vasileios Kouranos, Rakesh SharmaABSTRACT
Cardiac sarcoidosis can be life‐threatening, and lack of response to immunosuppressive therapy remains a significant challenge in active disease. We present a case of refractory cardiac sarcoidosis despite third‐line immunosuppression (infliximab). Ongoing multimodality assessment is essential for managing refractory cardiac sarcoidosis.